Kunin M et al. |
Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review. |
2014 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:24569948
|
Fan Y et al. |
High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis. |
2014 |
J Laryngol Otol |
pmid:24555753
|
Hanson KE et al. |
Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing? |
2014 |
J. Clin. Microbiol. |
pmid:24554745
|
Almeida N et al. |
Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study. |
2014 |
Helicobacter |
pmid:24506175
|
Lara-MartÃn PA et al. |
Occurrence, distribution and partitioning of nonionic surfactants and pharmaceuticals in the urbanized Long Island Sound Estuary (NY). |
2014 |
Mar. Pollut. Bull. |
pmid:24467856
|
Yakoob J et al. |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori. |
2014 |
Microb. Drug Resist. |
pmid:23844851
|
Markert C et al. |
Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteers. |
2014 |
Br J Clin Pharmacol |
pmid:23738582
|
Furuta T et al. |
Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy. |
2014 |
J Clin Pharmacol |
pmid:24122836
|
Khoshnood A et al. |
Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial. |
2014 |
J Med Life |
pmid:25408735
|
Fowler J and Mahlen SD |
Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria. |
2014 |
Arch. Pathol. Lab. Med. |
pmid:25076301
|
Ueda Y et al. |
[Obstructive pneumonia and brain abscess due to Nocardia elegans in a patient with systemic lupus erythematosus]. |
2014 |
Kansenshogaku Zasshi |
pmid:24974451
|
NegrÃn-González J et al. |
Psychiatric adverse reaction induced by clarithromycin. |
2014 |
Eur Ann Allergy Clin Immunol |
pmid:24853570
|
Kurosaki Y et al. |
[Two cases of pulmonary Mycobacterium avium complex disease with resistance to clarithromycin]. |
2014 |
Kekkaku |
pmid:24979948
|
Iwanaga K and Carter ER |
Mycobacterium abscessus complex lung infection in a toddler with a tracheostomy. |
2014 |
Pediatr. Pulmonol. |
pmid:23460506
|
Campanale M et al. |
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. |
2014 |
Dig. Dis. Sci. |
pmid:24595654
|
Schuhfried G et al. |
Gilles de la Tourette Syndrome caused by Mycoplasma pneumoniae successfully treated with macrolides. |
2014 |
Klin Padiatr |
pmid:25153913
|
Svanström H et al. |
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study. |
2014 |
BMJ |
pmid:25139799
|
Giamarellos-Bourboulis EJ et al. |
Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial. |
2014 |
J. Antimicrob. Chemother. |
pmid:24292991
|
Tümgör G et al. |
Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children. |
2014 |
Turk J Gastroenterol |
pmid:25910378
|
Çiftci İH et al. |
Comparison of FISH, RFLP and agar dilution methods for testing clarithromycin resistance of Helicobacter pylori. |
2014 |
Turk J Gastroenterol |
pmid:25910373
|
Oztürk K et al. |
Diagnosis of helicobacter pylori infection. |
2014 |
Turk J Gastroenterol |
pmid:25141328
|
Zhou L et al. |
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. |
2014 |
Am. J. Gastroenterol. |
pmid:24642580
|
Heo J and Jeon SW |
[Changes in the eradication rate of conventional triple therapy for Helicobacter pylori infection in Korea]. |
2014 |
Korean J Gastroenterol |
pmid:24651586
|
Kang BK et al. |
[New therapeutic strategies against Helicobacter pylori]. |
2014 |
Korean J Gastroenterol |
pmid:24651587
|
Lee JY and Kim N |
[Future trends of Helicobacter pylori eradication therapy in Korea]. |
2014 |
Korean J Gastroenterol |
pmid:24651589
|
Lee SH et al. |
The drug resistance profile of Mycobacterium abscessus group strains from Korea. |
2014 |
Ann Lab Med |
pmid:24422193
|
Patsche CB et al. |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement. |
2014 |
Int. J. Infect. Dis. |
pmid:25008771
|
Pathak V et al. |
Macrolide use leads to clinical and radiological improvement in patients with cryptogenic organizing pneumonia. |
2014 |
Ann Am Thorac Soc |
pmid:24460438
|
Jesus FP et al. |
In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25001300
|
Wu JY et al. |
Evidence-based recommendations for successful Helicobacter pylori treatment. |
2014 |
Expert Rev Gastroenterol Hepatol |
pmid:24410470
|
Sugamata R et al. |
Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression. |
2014 |
J. Antibiot. |
pmid:24496145
|
DÃaz Cuevas Z et al. |
[Nodular skin lesions in a patient with rheumatoid arthritis under therapy with anti-tumor necrosis factor-α]. |
2014 |
Med Clin (Barc) |
pmid:23877097
|
Jung YS et al. |
[Trends in the eradication rates of Helicobacter pylori infection in Daegu and Gyeongsangbuk-do, Korea: multicenter study over 13 years]. |
2014 |
Korean J Gastroenterol |
pmid:24561694
|
Vanderpas J et al. |
Follow-up of Helicobacter pylori infection in children over two decades (1988-2007): persistence, relapse and acquisition rates. |
2014 |
Epidemiol. Infect. |
pmid:23809783
|
Koh S et al. |
Visualization of the meibomian glands by means of noncontact mobile-type meibography (Meibopen) in a 16-year-old girl with unilateral marginal staphylococcal keratitis. |
2014 |
J AAPOS |
pmid:24568999
|
Mendu ML and Waikar SS |
Drug-drug interactions and acute kidney injury: caveat prescriptor. |
2014 |
Am. J. Kidney Dis. |
pmid:24820318
|
Maurer FP et al. |
Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus. |
2014 |
J. Antimicrob. Chemother. |
pmid:24500188
|
Farley R et al. |
Antibiotics for bronchiolitis in children under two years of age. |
2014 |
Cochrane Database Syst Rev |
pmid:25300167
|
de Masson A et al. |
Cavitary pulmonary disease in a patient treated with natalizumab. |
2014 |
Presse Med |
pmid:24742610
|
Furuta T et al. |
Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan. |
2014 |
J. Gastroenterol. Hepatol. |
pmid:24224808
|
Page SR and Yee KC |
Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin. |
2014 |
Intern Med J |
pmid:25041770
|
Noguchi S et al. |
Polymorphic transformation of antibiotic clarithromycin under acidic condition. |
2014 |
J Pharm Sci |
pmid:24375227
|
Phillips RO et al. |
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24323473
|
Hajaghamohammadi A et al. |
Low dose furazolidone for eradication of H- pylori instead of clarithromycin: a clinical trial. |
2014 |
Glob J Health Sci |
pmid:25560342
|
Iwanczak B et al. |
Genotypic and clinical differences of seropositive Helicobacter pylori children and adults in the Polish population. |
2014 |
J. Physiol. Pharmacol. |
pmid:25554984
|
McNicholl AG et al. |
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice. |
2014 |
Gut |
pmid:23665990
|
Rakici H et al. |
Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of Helicobacter pylori as first-line therapy. |
2014 |
Digestion |
pmid:25547786
|
Karamanolis GP et al. |
The evolution of Helicobacter pylori antibiotics resistance over 10 years in Greece. |
2014 |
Digestion |
pmid:25531953
|
Hemphill A et al. |
Treatment of echinococcosis: albendazole and mebendazole--what else? |
2014 |
Parasite |
pmid:25526545
|
Kawai T et al. |
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). |
2014 |
J. Gastroenterol. Hepatol. |
pmid:25521730
|
Srinarong C et al. |
Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:25520127
|
Hashim H et al. |
Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease. |
2014 |
PLoS ONE |
pmid:25411976
|
Wang B et al. |
Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis. |
2014 |
World J. Gastroenterol. |
pmid:25356059
|
Yangco BG et al. |
Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART? |
2014 |
AIDS Patient Care STDS |
pmid:24833016
|
Homma S et al. |
The successful management of respiratory complications with long-term, low-dose macrolide administration in pediatric heart transplant recipients. |
2014 |
Int Heart J |
pmid:25297501
|
Renvoisé A et al. |
Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare. |
2014 |
J. Clin. Microbiol. |
pmid:25274991
|
Tu S and Yang H |
[Progress in the treatment of Helicobacter pylori infection]. |
2014 |
Zhong Nan Da Xue Xue Bao Yi Xue Ban |
pmid:25269503
|
Malfertheiner P and Selgrad M |
Helicobacter pylori. |
2014 |
Curr. Opin. Gastroenterol. |
pmid:25268839
|
Ito Y et al. |
The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease. |
2014 |
BMC Infect. Dis. |
pmid:25266993
|
de Miguel-Martinez I et al. |
[Bacteriemia due to Mycobacterium canariasense in an oncohematological patient with a long-term central device]. |
2014 |
Enferm. Infecc. Microbiol. Clin. |
pmid:25262854
|
Higgins JW et al. |
Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1. |
2014 |
Drug Metab. Dispos. |
pmid:25106415
|
Boleda MR et al. |
Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters. |
2014 |
Environ Sci Pollut Res Int |
pmid:24756682
|
Nilsson MF and Webster WS |
Effects of macrolide antibiotics on rat embryonic heart function in vitro. |
2014 |
Birth Defects Res. B Dev. Reprod. Toxicol. |
pmid:24753334
|
Gold BD |
Resistance testing for Helicobacter pylori infection: is it finally ready for prime time? |
2014 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:25222802
|
Morakul B et al. |
Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method. |
2014 |
Eur J Pharm Biopharm |
pmid:25201298
|
Parekh TM et al. |
Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas. |
2014 |
JAMA Intern Med |
pmid:25179404
|
Kutluk G et al. |
Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains? |
2014 |
Eur J Gastroenterol Hepatol |
pmid:25171023
|
Higashi F et al. |
Additional treatment with clarithromycin reduces fever duration in patients with influenza. |
2014 |
Respir Investig |
pmid:25169846
|
de Boer EM et al. |
[Antibiotic resistance of Helicobacter pylori: prevalence in one region in the southern Netherlands and implications for treatment]. |
2014 |
Ned Tijdschr Geneeskd |
pmid:25159698
|
Wallace RJ et al. |
Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease. |
2014 |
Chest |
pmid:24457542
|
Molina-Infante J and Gisbert JP |
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:25132750
|
Heo J et al. |
A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication. |
2014 |
Dig Liver Dis |
pmid:25132282
|
Bansal S and Chhibber S |
Phytochemical-induced reduction of pulmonary inflammation during Klebsiella pneumoniae lung infection in mice. |
2014 |
J Infect Dev Ctries |
pmid:25022293
|
Fouka E et al. |
Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients. |
2014 |
Lung |
pmid:25016929
|
Lambert D et al. |
Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients. |
2014 |
Med Mal Infect |
pmid:25015308
|
Teh X et al. |
Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala Lumpur. |
2014 |
PLoS ONE |
pmid:25003707
|
Lyons J et al. |
An unusual lung mass post stem cell transplantation. |
2014 |
Transpl Infect Dis |
pmid:24995624
|
Lee JW et al. |
A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea. |
2014 |
Scand. J. Gastroenterol. |
pmid:24988873
|
Rakici H et al. |
Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates. |
2014 |
J Dig Dis |
pmid:24980811
|
Acosta CP et al. |
[Determination of single nucleotide mutations in the 23S rRNA gene of Helicobacter pylori related to clarithromycin resistance in a population from Cauca, Colombia]. |
2014 |
Biomedica |
pmid:24968047
|
Lee JW et al. |
GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. |
2014 |
Scand. J. Gastroenterol. |
pmid:24957849
|
Raffaldi I et al. |
An atypical deep neck infection in a two-year-old child. |
2014 |
Infez Med |
pmid:24955801
|
Oh DH et al. |
Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy. |
2014 |
J. Gastroenterol. Hepatol. |
pmid:24955448
|
Patel K et al. |
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity. |
2014 |
Int J Pharm |
pmid:24954663
|
Vafaeimanesh J et al. |
Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients. |
2014 |
Saudi J Kidney Dis Transpl |
pmid:24434382
|
Rasheed F et al. |
Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance. |
2014 |
Helicobacter |
pmid:24827414
|
Wang Y et al. |
Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis. |
2014 |
Helicobacter |
pmid:24826809
|
Pan-In P et al. |
Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori. |
2014 |
Carbohydr Polym |
pmid:24815396
|
Ichihara A et al. |
Case of disseminated cutaneous Mycobacterium chelonae infection mimicking cutaneous vasculitis. |
2014 |
J. Dermatol. |
pmid:24801916
|
Togami K et al. |
Involvement of intestinal permeability in the oral absorption of clarithromycin and telithromycin. |
2014 |
Biopharm Drug Dispos |
pmid:24801141
|
Bernut A et al. |
In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24798271
|
Adebisi AO and Conway BR |
Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus. |
2014 |
Int J Pharm |
pmid:24792977
|
Bolhuis MS et al. |
In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis. |
2014 |
Eur. Respir. J. |
pmid:24791826
|
Zhao LJ et al. |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype. |
2014 |
World J. Gastroenterol. |
pmid:24782630
|
Peretz A et al. |
Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults. |
2014 |
J. Antibiot. |
pmid:24781955
|
Nishida T et al. |
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan. |
2014 |
World J. Gastroenterol. |
pmid:24764674
|
Zhou L et al. |
Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study. |
2014 |
Chin. Med. J. |
pmid:24762588
|
Okame M et al. |
Complete regression of early-stage gastric diffuse large B-cell lymphoma in an HIV-1-infected patient following Helicobacter pylori eradication therapy. |
2014 |
Clin. Infect. Dis. |
pmid:24585569
|
Mark TM et al. |
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma. |
2014 |
Leuk. Lymphoma |
pmid:24576165
|
Takazono T et al. |
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report. |
2014 |
BMC Infect. Dis. |
pmid:24576098
|